• Exelixis opens two-front patent dispute over Cabometyx copies Life Sciences IP Review Thu, 09 Jul 2026 22:18:28 GMT
• EXEL Stock Soars 26.8% in Three Months: Is There More Room for Growth? Yahoo Finance Thu, 09 Jul 2026 18:21:00 GMT
• Exelixis: STELLAR-303 Results Mixed, STELLAR-304 Success Likely (NASDAQ:EXEL) Seeking Alpha Thu, 09 Jul 2026 13:33:45 GMT
• Is Exelixis, Inc. (EXEL) Among the Best Under-the-Radar Stocks to Invest In? Yahoo Finance Wed, 08 Jul 2026 19:20:32 GMT
• Exelixis, Inc. (EXEL) Hit a 52 Week High, Can the Run Continue? Yahoo Finance Wed, 08 Jul 2026 13:15:04 GMT
• Axsome Therapeutics, Exelixis, Incyte Among 20 New Stocks On IBD's Premier Watchlists Investor's Business Daily Tue, 07 Jul 2026 22:25:00 GMT
• RBC Capital Adjusts Exelixis Price Target to $46 From $43, Maintains Sector Perform Rating marketscreener.com Tue, 07 Jul 2026 12:18:31 GMT
• Exelixis, Inc. (EXEL) Stock Analysis: A Biotech Powerhouse with Strong Revenue Growth and High Analyst Interest DirectorsTalk Interviews Mon, 06 Jul 2026 09:17:18 GMT
• Zanzalintinib Trial Outcomes And Index Exit Might Change The Case For Investing In Exelixis (EXEL) simplywall.st Mon, 06 Jul 2026 05:09:20 GMT
• Is Exelixis (EXEL) Undervalued Or Already Priced In On Its Oncology Growth Story? simplywall.st Sat, 04 Jul 2026 20:28:26 GMT
• analysts offer insights on healthcare companies: exelixis (exel) and santhera pharmaceuticals holding (othersphdf) The Globe and Mail Fri, 03 Jul 2026 10:42:00 GMT
• Exelixis Faces Balanced Risk-Reward Ahead of Key Catalysts, UBS Says Moomoo Thu, 02 Jul 2026 16:02:11 GMT
• UBS Adjusts Price Target on Exelixis to $52 From $43, Maintains Neutral Rating marketscreener.com Thu, 02 Jul 2026 14:00:18 GMT
• UBS raises Exelixis stock price target to $52 on pipeline outlook Investing.com Thu, 02 Jul 2026 13:40:41 GMT
• exel reiterated by hc wainwright & co. -- price target maintained at $56 GuruFocus Thu, 02 Jul 2026 13:11:57 GMT
• h.c. wainwright maintains exelixis(exel.us) with buy rating, maintains target price $56 富途牛牛 Thu, 02 Jul 2026 12:21:37 GMT
• H.C. Wainwright reiterates Exelixis stock rating at Buy, $56 target Investing.com Thu, 02 Jul 2026 11:40:32 GMT
• Analyst recommendations: Adobe, AA, Nike, Exelixis… marketscreener.com Thu, 02 Jul 2026 09:17:44 GMT
• Exelixis | 4: Statement of changes in beneficial ownership of securities-Officer Aftab Dana Moomoo Wed, 01 Jul 2026 13:04:26 GMT
• exelixis inc. (nasdaq:exel): a decent value play in the biotechnology sector ChartMill Wed, 01 Jul 2026 09:20:32 GMT
• What Does Truist’s New Analyst Think About Exelixis (EXEL) and Its Next-Generation Cancer Drug? Yahoo Finance Wed, 01 Jul 2026 07:00:00 GMT
• seven fleet capital management lp's exelixis inc(exel) holding history GuruFocus Mon, 29 Jun 2026 20:09:32 GMT
• Exelixis, Inc.(NasdaqGS: EXEL) dropped from Russell 1000 Growth-Defensive Index marketscreener.com Mon, 29 Jun 2026 13:46:24 GMT
• Exelixis, Inc. (EXEL) Stock Analysis: Biotechnology Leader with Robust Revenue Growth and High ROE DirectorsTalk Interviews Mon, 29 Jun 2026 09:17:51 GMT
• Enterprise value to EBITDA forward of Exelixis, Inc. – NASDAQ:EXEL TradingView Sun, 28 Jun 2026 05:49:34 GMT
• exelixis falls as final analysis of zanzalintinib phase 3 data disappoints MSN Sat, 27 Jun 2026 00:00:19 GMT
• Is Exelixis (EXEL) Fully Valued On Its STELLAR 303 Trial Update? simplywall.st Fri, 26 Jun 2026 23:46:01 GMT
• exelixis falls as final analysis of zanzalintinib phase 3 data disappoints MSN Fri, 26 Jun 2026 11:31:46 GMT
• Exelixis, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh Actuals & Estimates (BMFBOVESPA:E2XE34) TradingView Fri, 26 Jun 2026 11:27:43 GMT
• enterprise value to revenue forward of exelixis, inc. – nasdaq:exel TradingView Fri, 26 Jun 2026 08:28:13 GMT
• exelixis inc (exel) financial health: profitability & balance sheet analysis TradingKey Fri, 26 Jun 2026 07:38:26 GMT
• price to sales forward of exelixis, inc. unsponsored brazilian depositary receipt repr 0.5 sh – bmfbovespa:e2xe34 TradingView Fri, 26 Jun 2026 03:00:23 GMT
• exel downgraded by truist securities -- price target raised to $54 GuruFocus Thu, 25 Jun 2026 15:15:10 GMT
• Truist Financial Downgrades Exelixis(EXEL.US) to Hold Rating, Raises Target Price to $54 Moomoo Thu, 25 Jun 2026 11:31:00 GMT
• exelixis, inc. unsponsored brazilian depositary receipt repr 0.5 sh TradingView Thu, 25 Jun 2026 08:21:55 GMT
• Truist assumes Exelixis stock coverage with Hold rating on pipeline uncertainty Investing.com Thu, 25 Jun 2026 07:00:00 GMT
• EXELIXIS INC : TRUIST SECURITIES CUTS TO HOLD FROM BUY; RAISES TARGET PRICE TO $54 FROM $51 Moomoo Thu, 25 Jun 2026 07:00:00 GMT
• does stellar-303’s mixed survival signal reshape the bull case for exelixis’ pipeline strategy (exel)? simplywall.st Thu, 25 Jun 2026 07:00:00 GMT
• price to earnings forward of exelixis, inc. – nasdaq:exel TradingView Thu, 25 Jun 2026 06:07:01 GMT
• enterprise value to ebit forward of exelixis, inc. – nasdaq:exel TradingView Thu, 25 Jun 2026 05:36:09 GMT
• exel maintained by citizens -- price target raised to $55.00 GuruFocus Wed, 24 Jun 2026 14:14:16 GMT
• citizens jmp forecasts strong price appreciation for exelixis (nasdaq:exel) stock MarketBeat Wed, 24 Jun 2026 13:13:16 GMT
• exelixis inc (exel) financial health: profitability & balance sheet analysis TradingKey Wed, 24 Jun 2026 09:41:08 GMT
• exel down on colorectal cancer study data on zanzalintinib Yahoo Finance Singapore Tue, 23 Jun 2026 18:24:00 GMT
• Exelixis' TKI falls short in colorectal cancer subgroup as FDA reviews approval in all-comers Endpoints News Tue, 23 Jun 2026 11:05:00 GMT
• BofA Securities Maintains Exelixis(EXEL.US) With Sell Rating, Maintains Target Price $41 Moomoo Tue, 23 Jun 2026 07:00:00 GMT
• exelixis inc (exel) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• Exelixis’ Cabometyx successor fails primary endpoint in colorectal cancer trial amid FDA review Fierce Biotech Mon, 22 Jun 2026 19:40:29 GMT
• exelixis provides 'a highly defensive investment profile:' analyst Benzinga Mon, 22 Jun 2026 17:38:33 GMT
• exelixis (exel) shares decline after trial analysis shows no sta GuruFocus Mon, 22 Jun 2026 16:26:59 GMT
• exelixis (exel) reports phase 3 trial results for cancer treatme GuruFocus Mon, 22 Jun 2026 16:03:35 GMT
• Exelixis Provides Update on the Phase 3 STELLAR-303 Trial Evaluating Zanzalintinib in Combination with an Immune Checkpoint Inhibi... Yahoo Finance Mon, 22 Jun 2026 07:00:00 GMT
• Exelixis falls as final analysis of zanzalintinib phase 3 data disappoints Seeking Alpha Mon, 22 Jun 2026 07:00:00 GMT
• Morgan Stanley reiterates Exelixis stock rating on mixed trial data Investing.com Mon, 22 Jun 2026 07:00:00 GMT
• exelixis reports mixed results from colorectal cancer trial Investing.com Mon, 22 Jun 2026 07:00:00 GMT
• exelixis provides update on the phase 3 stellar-303 trial evaluating zanzalintinib in combination with an immune checkpoint inhibi... Business Wire Sun, 21 Jun 2026 07:00:00 GMT
• exelixis inc (exel) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 17:10:46 GMT
• exelixis inc (exel) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 09:24:19 GMT
• exelixis inc (exel) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 09:23:12 GMT
• exelixis inc (exel) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 06:32:21 GMT
• exelixis inc (exel) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 20:56:43 GMT
• how investors are reacting to exelixis (exel) cabometyx neuroendocrine tumor phase 3 win at asco simplywall.st Wed, 17 Jun 2026 14:57:27 GMT
• exelixis inc (exel) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 08:21:37 GMT
• exelixis inc (exel) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 08:20:46 GMT
• exelixis inc (exel) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• exelixis inc stock (us30161q1040): quarterly earnings in focus after recent results AD HOC NEWS Mon, 15 Jun 2026 14:10:40 GMT
• Exelixis CABINET Win Extends CABOMETYX Reach And Raises Valuation Questions Yahoo Finance Sat, 13 Jun 2026 07:00:00 GMT
• prostate cancer pipeline 2026: therapies, moa insights, and key clinical trial updates by delveinsight | telix pharma, merck, orio... Barchart.com Wed, 10 Jun 2026 22:30:06 GMT
• goldman sachs group inc. purchases 1,113,916 shares of exelixis, inc. $exel MarketBeat Wed, 10 Jun 2026 09:08:33 GMT
• cibc world market inc. purchases 31,985 shares of exelixis, inc. $exel MarketBeat Wed, 10 Jun 2026 07:54:22 GMT
• bi asset management fondsmaeglerselskab a s has $1.91 million position in exelixis, inc. $exel MarketBeat Wed, 10 Jun 2026 07:44:14 GMT
• Exelixis Hits High on Growing Sales, Institutional Inflows Yahoo Finance Wed, 10 Jun 2026 07:00:00 GMT
• exelixis (exel) valuation check after cabinet trial data fuels renewed growth optimism Sahm Wed, 10 Jun 2026 07:00:00 GMT
• exelixis stock hits all-time high at 52.98 usd by investing.com Investing.com Canada Wed, 10 Jun 2026 00:01:05 GMT
• exelixis stock hits all-time high at 52.98 usd by investing.com Investing.com Nigeria Tue, 09 Jun 2026 16:05:05 GMT
• bank of new york mellon corp cuts position in exelixis, inc. $exel MarketBeat Tue, 09 Jun 2026 07:18:16 GMT
• exelixis inc (nasdaq:exel) offers decent value with strong profitability and financial health ChartMill Tue, 09 Jun 2026 07:00:00 GMT
• exelixis, inc. $exel position increased by northwestern mutual wealth management co. MarketBeat Mon, 08 Jun 2026 09:26:37 GMT
• exelixis, inc. (exel) stock analysis: a promising player in biotechnology with strong revenue growth DirectorsTalk Interviews Mon, 08 Jun 2026 09:14:28 GMT
• los angeles capital management llc has $49.57 million holdings in exelixis, inc. $exel MarketBeat Sun, 07 Jun 2026 10:57:43 GMT
• exel collaborates with mrk for late-stage colorectal cancer study MSN Sun, 07 Jun 2026 09:29:02 GMT
• commonwealth equity services llc sells 259,643 shares of exelixis, inc. $exel MarketBeat Sun, 07 Jun 2026 08:40:43 GMT
• how broad cabometyx pfs benefit at exelixis (exel) has changed its investment story simplywall.st Sun, 07 Jun 2026 01:23:34 GMT
• 168,437 shares in exelixis, inc. $exel purchased by winton group ltd MarketBeat Sat, 06 Jun 2026 12:03:59 GMT
• cabinet results broaden cabometyx neuroendocrine reach and investor considerations Sahm Sat, 06 Jun 2026 07:00:00 GMT
• exelixis (nasdaq:exel) reaches new 52-week high - time to buy? MarketBeat Fri, 05 Jun 2026 19:43:52 GMT
• cabinet results broaden cabometyx neuroendocrine reach and investor considerations simplywall.st Fri, 05 Jun 2026 07:00:00 GMT
• exelixis, inc. (exel) stock price, news, quote & history Yahoo Finance Thu, 04 Jun 2026 15:44:49 GMT
• Exelixis (EXEL) Up 6% Since Last Earnings Report: Can It Continue? Yahoo Finance Thu, 04 Jun 2026 07:00:00 GMT
• why exelixis (exel) is a top growth stock for the long-term Yahoo Finance Thu, 04 Jun 2026 07:00:00 GMT
• insider sell alert: jack wyszomierski sells 3,925 shares of exelixis inc (exel) GuruFocus Thu, 04 Jun 2026 01:52:30 GMT
• exelixis inc at jefferies global healthcare conference in new york transcript GuruFocus Thu, 04 Jun 2026 01:47:36 GMT
• exelixis director jack wyszomierski sells $198,408 in shares Investing.com Thu, 04 Jun 2026 00:28:24 GMT
• exelixis director sue eckhardt sells $491,973 in stock Investing.com Thu, 04 Jun 2026 00:23:40 GMT
• exelixis (exel) director eckhardt sells 9,812 shares under 10b5-1 plan Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• planned share sale by exelixis (nasdaq: exel) director wyszomierski Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• why exelixis (exel) is a top value stock for the long-term Yahoo Finance Wed, 03 Jun 2026 07:00:00 GMT
• exelixis director jack wyszomierski sells $198,408 in shares Investing.com Wed, 03 Jun 2026 07:00:00 GMT
• exelixis director sue eckhardt sells $491,973 in stock Investing.com Wed, 03 Jun 2026 07:00:00 GMT
• exelixis, inc. $exel shares purchased by bnp paribas financial markets MarketBeat Wed, 03 Jun 2026 07:00:00 GMT
• exelixis, inc. (exel) stock price, news, quote & history Yahoo Finance Wed, 03 Jun 2026 00:19:07 GMT
• if decades of history tell us anything, this biotech near $50 is primed to skyrocket AOL.com Tue, 02 Jun 2026 19:19:14 GMT
• geode capital management llc sells 141,796 shares of exelixis, inc. $exel MarketBeat Tue, 02 Jun 2026 07:00:00 GMT
• exelixis, inc. (exel) stock analysis: a biotech powerhouse with robust revenue growth and strong analyst support DirectorsTalk Interviews Mon, 01 Jun 2026 09:15:29 GMT
• why exelixis (exel) is a top momentum stock for the long-term Yahoo Finance Mon, 01 Jun 2026 07:00:00 GMT
• exel collaborates with mrk for late-stage colorectal cancer study MSN Mon, 01 Jun 2026 06:13:59 GMT
• exelixis (exel) reports positive phase 3 trial results for cabom GuruFocus Sun, 31 May 2026 16:59:09 GMT
• exelixis, inc. (exel) stock price, news, quote & history Yahoo Finance Sat, 30 May 2026 21:06:12 GMT
• exelixis announces positive results for its drug cabometyx in the treatment of neuroendocrine tumors Bitget Sat, 30 May 2026 14:36:16 GMT
• should new asco colorectal cancer data on zanzalintinib reshape exelixis' (exel) investment narrative? simplywall.st Sat, 30 May 2026 14:17:05 GMT
• Exelixis, Inc. (EXEL): Renaissance Technologies Likes This Stock Yahoo Finance Sat, 30 May 2026 07:00:00 GMT
• Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX Business Wire Sat, 30 May 2026 07:00:00 GMT
• exelixis says cabometyx reduces risk of progression or death by 74% in non-functional net, 60% in functional net TradingView Sat, 30 May 2026 07:00:00 GMT
• exelixis presents cabometyx data for neuroendocrine tumors Investing.com Sat, 30 May 2026 07:00:00 GMT
• exelixis announces positive results for its drug cabometyx in the treatment of neuroendocrine tumors Bitget Fri, 29 May 2026 23:30:41 GMT
• exelixis evp aftab dana sells $2.19 million in common stock by investing.com Investing.com South Africa Fri, 29 May 2026 08:16:31 GMT
• Exelixis Announces First Quarter 2026 Financial Results and Provides Corporate Update Business Wire Fri, 29 May 2026 07:00:00 GMT
• How The Exelixis (EXEL) Story Is Shifting As Wall Street Reworks Fair Value Targets Yahoo Finance Fri, 29 May 2026 07:00:00 GMT
• how investors are reacting to exelixis (exel) expanding beyond cabometyx with new colorectal cancer trials Yahoo Finance Fri, 29 May 2026 07:00:00 GMT
• 8,367-share rsu grant boosts exelixis (nasdaq: exel) director holdings Stock Titan Fri, 29 May 2026 07:00:00 GMT
• exelixis announces results from subgroup analysis of phase 3 cabinet pivotal trial evaluating cabometyx Business Wire Fri, 29 May 2026 07:00:00 GMT
• exelixis (exel) director receives option grant tied to caligan funds Stock Titan Fri, 29 May 2026 07:00:00 GMT
• exelixis (nasdaq: exel) director granted 8,367 rsus, now holds 50,649 shares Stock Titan Fri, 29 May 2026 07:00:00 GMT
• director julie smith (exel) receives 8,367 rsus vesting in 2027 Stock Titan Fri, 29 May 2026 07:00:00 GMT
• exelixis (exel) director mary beckerle receives 8,367 rsu equity grant Stock Titan Fri, 29 May 2026 07:00:00 GMT
• exelixis (exel) director oliver bob receives 8,367 rsus as equity grant Stock Titan Fri, 29 May 2026 07:00:00 GMT
• exelixis (exel) director stelios papadopoulos receives 8,367 rsu grant Stock Titan Fri, 29 May 2026 07:00:00 GMT
• exelixis (exel) director receives 8,367 rsus vesting in 2027 Stock Titan Fri, 29 May 2026 07:00:00 GMT
Exelixis, Inc(NASDAQ:EXEL) 
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who receiv...
Website: http://www.exelixis.com
Founded: 1994
Full Time Employees: 617
Sector: Healthcare
Industry: Biotechnology